PD-L1 expression has been correlated with poor clinical outcome in several cancer types, although PD-L1 has been associated with improved survival and increased TIL frequency in some reports15, 16, 17, 18, 19, 20, 21, 22. This evidence concerns the gene CD274 and cancer.